sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Peptide Cancer Vaccine Market Scope And Analysis

  • Report Code : TIPRE00027673
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi dell'ambito di mercato e dei concorrenti dei vaccini peptidici contro il cancro entro il 2025-2031

Buy Now

Peptide Cancer Vaccine Market Report Peptide Cancer Vaccine Market Size and Share Peptide Cancer Vaccine Market Scope and Analysis

Peptide Cancer Vaccine Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 20.2%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Tipo di cancro
  • tumore al seno
  • cancro ai polmoni
  • melanoma
  • cancro alla prostata
  • altri
By Tipo di vaccino
  • vaccino peptidico personalizzato
  • vaccino contro il cancro dendritico pulsato con peptidi
  • tipo cocktail di peptidi
  • vaccino peptidico multivalente
  • altri
By Geografia
  • Nord America
  • Europa
  • Asia-Pacifico
  • Sud e Centro America
  • Medio Oriente e Africa
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Enzo Life Science
  • Immatics Biotechnologies
  • TapImmune
  • Merck
  • BrightPath Biotherapeutics
  • Sellas
  • BioLife Science
  • Boston Biomedical
  • VAXON Biotech